Case Study
Trial Tokenization to Understand the Long Term Effectiveness of a New COVID-19 Vaccine
A biopharma company was conducting a Phase III study to assess the safety and effectiveness of a new COVID-19 vaccine. They needed to identify and connect to real-world data sources that would enable observation of infection rates and adverse events beyond the period of the trial.
Read More